"Patient Access Location; Research Institute; Alzheimer's Prevention Research"

During the past decade, Care Access Research LLC conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 4 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 4 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Care Access Research LLC" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Exact Sciences Corporation" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Arena Pharmaceuticals" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Care Access Research LLC" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Valneva Austria GmbH" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Care Access Research LLC" are "Ulcerative Colitis" (4 trials), "Crohn's Disease" (3 trials), "Colorectal Cancer" (2 trials), "Alzheimer Disease" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Care Access Research LLC" in a lesser frequency.

Most popular intervention types in "Care Access Research LLC" are "Drug" (12 trials), "Biological" (3 trials), "Other" (2 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Guselkumab" (3 trials), "Mirikizumab" (3 trials), "Golimumab" (2 trials) and "Guselkumab Dose 1" (2 trials). Other intervention names were less common.

The vast majority of trials in "Care Access Research LLC" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Care Access Research LLC". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Care Access Research LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Care Access Research LLC, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".